Skeletal Muscle Relaxants Dr Naser Ashraf. Types of skeletal muscle relaxants: 2 groups Neuromuscular blockers Relax normal muscles (surgery and assistance.

Slides:



Advertisements
Similar presentations
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 16 Drugs That Block Nicotinic Cholinergic Transmission: Neuromuscular Blocking.
Advertisements

INDIRECT CHOLINOMIMETICS Pharmacology Department
Drugs affecting neuromuscular transmission Professor Ian Hughes, 9.83; motor nerve - skeletal (striated) muscle ONLY single long.
SHANNON KEHR PHYSIOLOGY APRIL 1, 2014 Muscle Relaxers.
Pharmacology of Cholinesterase Inhibitors and Nicotinic Antagonists
Skeletal Muscle Relaxants (Neuromuscular Blocking Agents)
Skeletal Muscle Relaxants By S. Bohlooli, PhD. Drugs affecting skeletal muscle function Neuromuscular blockers Used during surgical procedures and ICU.
The Neuromuscular Junction
Agents Used to Treat Musculoskeletal Health Alterations.
Skeletal muscle relaxants
Pharmacology-1 PHL 313 Parasympathetic Nervous System Sixth Lecture By Abdelkader Ashour, Ph.D. Phone:
Pharmacology DOR 101 Abdelkader Ashour, Ph.D. 5 th Lecture.
Skeletal muscle relaxants
NEUROMUSCULAR JUNCTION BLOCKERS BY :DR ISRAA OMAR.
Skeletal Muscle Relaxants
MCMP 407 Spasmolytics Chronic neurologic diseases Cerebral Palsy, Multiple Sclerosis Acute Injury Spinal cord damage, muscle inflamation Goal of therapy:
Skeletal Muscle Relaxants
SKELETAL MUSCLE RELAXANTS
NEUROMUSCULAR BLOCKERS and CENTRAL MUSCLE RELAXANTS DR.ABDUL LATIF MAHESAR PHARMACOLOGY Dr.Alia Al-Shanawani December 17,2011 References: Basic and clinical.
Parasympathetic agonist & antagonist
Pharmacology-1 PHL 351, Parasympathetic Nervous System Abdelkader Ashour, Ph.D. 6 th Lecture.
HuBio 543 September 20, 2007 Neil M. Nathanson K-536A, HSB Introduction to the Autonomic Nervous System (ANS)
NEUROMUSCULAR JUNCTION BLOCKERS
1 Cholinergic Receptors Antagonists Section 2, lecture 3.
Skeletal muscle relaxants
11/22/20151 SKELETAL MUSCLE RELAXANTS. 211/22/2015 Classification on basis of site of action and mechanism of action A)PERIPHERALLY ACTING Neuromuscular.
Cholinergic antagonists
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 13 Drugs Affecting.
Pharmacology-1 PHL 211 Twelfth Lecture By Abdelkader Ashour, Ph.D. Phone:
Antispastics & Spasmolytic drugs that act centrally
Cholinergic antagonists Samuel Aguazim ( MD). What are cholinergic antagonists? Drugs that bind to cholinergic receptors ( muscarinic and/or nicotinic),
Skeletal Muscle Relaxants
Muscle Relaxants are classified as: I)Peripherally acting A.Neuromuscular blocking agents :- 1) Depolarizing muscle relaxants. 2) Non-depolarizing muscle.
INDIRECT CHOLINOMIMETICS Prof. Alhaider Pharmacology Department Prof. Hanan Hagar Pharmacology Department.
Rapacuronium: 1. Is a depolarising muscle relaxant. 2. Is typically given in a dose of 1.5 mgs/kg. 3. Produces intubating conditions within 1 circulation.
Autonomic Nervous System 6-Anticholinergic Drugs
Dr: Samah Gaafar Al-shaygi بسم الله الرحمن الرحيم.
Pharmacology-1 PHL 313 Parasympathetic Nervous System Fifth Lecture By Abdelkader Ashour, Ph.D. Phone:
Parasympatholytics Dr. Zaker.
Cholinergic Antagonist. Overview Cholinergic antagonists bind to muscarinic and/or nicotinic receptors and block the actions of acetylcholine. There are.
Chapter 13 Drugs Affecting Muscle Function Copyright © 2011 Delmar, Cengage Learning.
Neuromuscular Blocking Agents Dr. Ahmed Haki Ismael.
(Cholinergic antagonists) (Anticholinergic ) (Cholinergic Blockers)
Skeletal Muscle Relaxants
Neuromuscular Blockers
Antinicotinics 1. Classification of Antinicotinics Antinicotinics Neuromuscular Junction blockers (NMJ) Ganglionic blockers 2. Medicinal Chemistry
Skeletal muscle relaxants
MUSCLE RELAXANTS Dr Walid Zuabi FCA RCSI.
Pharmacology-1 PHL 313 Sixth Lecture By Abdelkader Ashour, Ph.D. Phone:
MUSCLE RELAXANTS Muscle relaxants are drugs that interrupt transmission of neural impulses at the neuromuscular junction.
Skeletal Muscle Relaxants
Muscle Relaxants.
NEUROMUSCULAR BLOCKING AGENTS
Anticholinesterase Drugs and Cholinergic Agonists
Cholinesterase Inhibitors (Indirect acting cholinergic agonists)
SKELETAL MUSCLE RELAXANTS.
Skeletal Muscle Relaxants
Cholinergic Antagonist
Cholinergic Antagonist
Muscle Relaxants Dr Sura Al Zoubi
Cholinergic Antagonists
Muscle relaxants By Dr. Mirza Shahed Baig.
Skeletal muscle relaxants
SYMPATHETIC Increase BP & HR, glucose Perfusion to skeletal muscles Mydriasis, bronchodilatation PARASYMPATHETIC Miosis, decreased HR, BP, bronchia secretion,
Non -depolarizing muscle relaxant
Skeletal muscle relaxants
Cholinergic antagonists
Non -depolarizing muscle relaxant
Presentation transcript:

Skeletal Muscle Relaxants Dr Naser Ashraf

Types of skeletal muscle relaxants: 2 groups Neuromuscular blockers Relax normal muscles (surgery and assistance of ventilation) No central nervous system activity. Used primarily as a part of general anesthesia Spasmolytics Reduce spasticity Centrally acting (except dantrolene which act on the skeletal muscle) Used in a variety of neurologic conditions

Skeletal Muscle Relaxants Centrally acting Neuromuscular blockers Directly acting Spasmolytics Non-depolarizing Depolarizing (Competitive) D tubocurarine Pancuronium Vecuronium Atracurium Mivacurium (Non-Competitive) Succinylcholine Decamethomium Diazepam Chlorzoxazone Tizanidine Baclofen Dantrolene

Skeletal Muscle contraction Action Potential Ca 2+ Motor neuron Na + ACH          Na + Skeletal Muscle ACHEsterase N M receptor

Mechanism of action of Neuromuscular Blockers

Ach A SCh Contraction Relaxation Flaccid Paralysis Ch Depolarization No Depolarization Persistent Depolarization SCh No contraction Contraction Relaxation ( Fasciculation) Normald-TubocurarineSuccinylcholine Repolarization

Competitive Antagonists (Non-depolarizing Blockers)

(Non-depolarizing blockers) Long-acting: d tubocurarine, pancuronium Intermediate: Atracurium, vecuronium, rocuronium, Short-acting: Mivacurium

Mechanism of Action Competitive Antagonism Ach Agonist d-Tubocurarine Antagonist Motor End Plate Anti-cholinestrases (neostigmine, edrophonium) which preserve acetylcholine are used to reverse the effect of d-tubocurarine Affinity : Yes Intrinsic action : No N M receptor

Actions Muscle weakness  Flaccid paralysis Order of muscle affected: –Extrinsic eye muscles, muscles of finger –Neck muscles (muscles of phonation and swallowing) –Face –Hands, –Feet –Trunk –Respiratory muscles (intercostal and diaphragm) Recovery in the reverse order Consciousness, appreciation of pain not affected

Actions Autonomic ganglion blocking property Histamine release (by d-tubocurarine) CVS –Significant fall in BP –Increase in Heart rate –Vagal gangionic blockade (also ‘ve’ and ‘pan’) Newer competitive blockers: –Negligible effect on BP and HR

Adverse effects Hypotension Tachycardia Respiratory paralysis Bronchospasm Aspiration of gastric contents

Advantages of synthetic (Newer) competitive blockers Less histamine release Do not block autonomic ganglia Spontaneous recovery with most of drugs Rapacuronium & rocuronium have rapid onset Atracuronium: Hoffmans elimination Mivacurium short acting

Uses As an adjunct to general anaesthesia –For producing satisfactory skeletal muscle relaxation For facilitating endotracheal intubation –Rocuronium preferred due to rapid onset of action –Succinylcholine is better due to short lasting duration

Depolarizing Blocker (Non-competitive Antagonist) Succinylcholine One Drug, Two blocks, Brief and quick, Genetic variability in metabolism, Malignant hyperthermia

Succinyl Choline Acetylcholine Two molecules of Acetylcholine) Depolarising muscle relaxants Skeletal Muscle Relaxants Quaternary ammonium Quaternary ammonium

Mechanism of action Agonist at Nicotinic (N M ) receptor Produces neuromuscular block by overstimulation, end plate is unable to respond to further stimulation. Longer lasting or persistent depolarization

Actions Small rapidly moving muscles (eye, jaw, larynx) relax before those of limbs and trunks Ultimately intercostals and finally diaphragm paralysis occur  respiratory paralysis Recovery in the reverse order Muscle relaxation: Onset: within 1 min; peak: 2 min, duration: 5 min; longer duration relaxation requires continued IV infusion Succinylcholine

Uses Suitable for short-term procedures Rapid endotracheal intubation during induction of anaesthesia During Electro-Convulsive shock Therapy (ECT) –To prevent injury Succinylcholine

Adverse Effects Transient  Intraocular Tension Hyperkalemia : Fasciculations release potassium in blood Succinylcholine apnoea Malignant hyperthermia: when used alng with halothane in general anaesthesia –Treatment is by rapid cooling of patient & dantrolene i.v Muscle pain Succinylcholine

Treatment of succinylcholine apnoea No antidote is available Fresh frozen plasma should be infused Patient should be ventilated artificially untill full recovery

Comparison of Competitive and Depolarizing Blocking Agents Sr.noCompetitiveSuccinyl choline 1Competitive blockadePersistant depolarization 2Non depolarizingDepolarizing 3Single blockDual block 4Anticholinesterases reverse blockade Do not reverse 5Initial fasciculations not present Present 6Slow onset long duration Rapid onset short duration 7Release histamineDoesn’t release

Dantrolene Directly acting skeletal Muscle relaxant Inhibits depolarization induced calcium release from sarcoplasmic reticulum by acting on ryanodine receptors Drug of choice in malignant hyperthermia

Drug interactions Non depolarizing blockers –Anticholine-esterases (Neostigmine) Reverse the action of only non depolarizing blockers –Halothane, Aminoglycoside antibiotic like gentamicin & calcium channel blockers like nifedipine Enhances the neuromuscular blockade Depolarizing blockers –Halothane can cause malignant hyperthermia

Ganglion blockers Competitive blockers –Hexamethonium –Trimethaphan –Mecamylamine Persistant depolarizing –Nicotine large dose

Actions & Adverse effects of ganglion blockers S.NoOrganDominant ANSEffect/(side effect)of ganglionic blockade 1.HeartParasympatheticTachycardia (Palpitations) 2.Blood vesselsSympatheticVasodilation (Hypotension) 3.IrisParasympatheticMydriasis (Photophobia) 4.Ciliary MuscleParasympatheticCycloplegia (Blurring of vision) 5.IntestinesParasympathetic↓ motility (Constipation) 6.BladderParasympathetic↓ tone (difficulty in micturation) 7.Male sexual functionParasympatheticInhibition of erection & ejaculation (Impotence) 8.Salivary GlandsParasympatheticInhibition of salivation (dry mouth, difficulty in swallowing) 9.Sweat GlandsSympatheticInhibition of sweating